Table 1.
Compounds | Short-Term Cytotoxicity |
Long-Term Cytotoxicity |
Most Effective Dose | Fold Change of COX-2 |
Fold Change of IL-6 |
---|---|---|---|---|---|
Psi | N/A | N/A | 40 μM | −3.8× | N/A |
4-AcO-DMT | N/A | N/A | 20 μM | −1.5× | N/A |
Ket | ≥40 μM | ≥5 μM | 1 μM | −1.7× | N/A |
Cap | ≥50 μM | ≥0.5 μM | 0.5 μM | −1.6× | N/A |
Cur | ≥5 μM | ≥1 μM | 0.5 μM | −3.8× | N/A |
Eug | ≥10 μM | ≥10 μM | 50 μM | −3.8× | N/A |
Psi + Cap | N/A | 10 μM Psi, ≥0.5 μM Cap |
20 μM Psi, 0.5 μM Cap |
−3.8× | −1.7× |
Psi + Cur | 10 μM Psi & 1 μM Cur |
10/20 μM Psi, ≥0.5 μM Cur |
40 μM Psi, 0.5 μM Cur |
−28× | −1.6× |
Psi + Eug | N/A | N/A | 40 μM Psi, 25 μM Eug |
−19× | −10× |
4-AcO-DMT + Cap | N/A | N/A | 20 μM 4-AcO-DMT, 0.5 μM Cap |
−1.1× | −3.3× |
4-AcO-DMT + Cur | N/A | 10 μM 4-AcO-DMT, ≥0.5 μM Cur |
40 μM 4-AcO-DMT, 0.5 μM Cur |
−1.3× | −1.3× |
4-AcO-DMT + Eug | N/A | N/A | 40 μM 4-AcO-DMT, 25 μM Eug |
−1.6× | −1.5× |
Ket + Cap | N/A | N/A | 5 μM Ket, 0.5 μM Cap |
−2.1× | −2.0× |
Ket + Cur | N/A | 10 μM Ket, ≥0.5 μM Cur |
1 μM Ket, 0.5 μM Cur |
−3.5× | −1.1× |
Ket + Eug | N/A | ≥1 μM Ket, 25 μM Eug |
10 μM Ket, 25 μM Eug |
−2.8× | −3.0× |
4-AcO-DMT, 4-acetoxy-N,N-dimethyltryptamine; Cap, capsaicin; Cur, curcumin; Eug, eugenol; Ket, ketanserin; Psi, psilocybin.